Stock Markets February 16, 2026 11:35 AM

Warsaw session closes higher as energy, banking and oil & gas names lead modest gains

WIG30 posts a small advance as mixed breadth and commodity moves accompany trading

By Avery Klein
Warsaw session closes higher as energy, banking and oil & gas names lead modest gains

Poland's main blue-chip gauge, the WIG30, ended the trading session higher, supported by advances in Energy, Banking and Oil & Gas stocks. The index rose 0.28% at the close in Warsaw, with several individual large-cap names posting notable moves. Market breadth was mixed and commodity and currency markets registered modest shifts during the session.

Key Points

  • WIG30 closed up 0.28% at the Warsaw session close, led by advances in Energy, Banking and Oil & Gas sectors.
  • Top individual performers included Tauron Polska Energia (WA:TPE) +2.85%, Bank Millennium (WA:MILP) +2.79% and Santander Bank Polska (WA:SPL1) +1.87%; largest decliner was KGHM (WA:KGH) -3.91%.
  • Market breadth was mixed - 270 decliners versus 263 advancers with 112 unchanged - while crude, Brent and gold futures, plus EUR/PLN and USD/PLN, posted modest moves.

Polish equities closed higher on Monday, with the large-cap WIG30 index finishing up 0.28% at the Warsaw close. Gains were concentrated in the Energy, Banking and Oil & Gas sectors, which collectively propelled the benchmark into positive territory by the session's end.

Among the WIG30 constituents, Tauron Polska Energia SA (WA:TPE) recorded the strongest advance, rising 2.85% - an increase of 0.32 points - to finish at 11.35. Bank Millennium SA (WA:MILP) added 2.79%, or 0.47 points, closing at 17.32. Santander Bank Polska SA (WA:SPL1) also contributed to the upward momentum, gaining 1.87% - a move of 11.00 points - to settle at 598.00.

Not all large-cap names participated in the rally. KGHM Polska Miedz SA (WA:KGH) was the weakest performer on the WIG30, dropping 3.91% - a decline of 12.40 points - to end the session at 305.00. Jastrzebska Spotka Weglowa SA (WA:JSW) slipped 0.99% or 0.27 points to 26.91, while Zabka Group SA (WA:ZAB) declined 0.68% or 0.15 points, finishing at 21.95.

Market breadth on the Warsaw Stock Exchange was narrowly negative, with 270 issues falling and 263 advancing; 112 shares finished unchanged. That distribution left the headline index slightly higher despite a near-even split between decliners and advancers.

Commodity markets registered modest moves alongside the equity session. US crude oil for April delivery rose 1.21%, gaining 0.76 to trade at $63.51 per barrel. Brent oil for April delivery climbed 1.15%, up 0.78 to $68.53 per barrel. In metals, the April Gold Futures contract decreased by 0.76%, a drop of 38.50, to trade at 5,007.80 a troy ounce.

Currency markets showed small shifts against the zloty. The euro strengthened versus the Polish zloty, with EUR/PLN up 0.17% to 4.21. The US dollar also moved higher against the zloty, with USD/PLN rising 0.28% to 3.55. The US Dollar Index Futures was trading up 0.16% at 96.97.


Below are key takeaways and considerations drawn strictly from the session's reported outcomes.

Risks

  • Narrow market breadth - with nearly as many declining issues (270) as advancing (263) - could indicate limited participation in the rally, posing a risk for sectors reliant on broad market strength (affects Energy, Banking and Oil & Gas).
  • Notable single-stock weakness, such as KGHM's 3.91% decline, highlights company-specific downside risk within the materials and mining sector.
  • Volatility in commodity prices - crude and Brent rose over 1% while gold futures fell 0.76% - may introduce uncertainty for commodity-linked sectors and firms sensitive to input or output price swings.

More from Stock Markets

Tech and Energy Stocks Drive Wide Swings as Mega-Caps Lead Movers Apr 8, 2026 Markets Brace for Core PCE, Jobless Claims and GDP Data on April 9, 2026 Apr 8, 2026 SpaceX assembling a vertically integrated 'sovereign' AI stack, Munster says Apr 8, 2026 Trio Petroleum Shares Plummet After Fresh At-the-Market Share Sales Apr 8, 2026 Plus Therapeutics Shares Jump After FDA Grants Orphan Drug Status to REYOBIQ Apr 8, 2026